Hemogenyx Pharmaceuticals secures £709k of new investment
Hemogenyx Pharmaceuticals PLC (LSE:HEMO, OTC:HOPHF) has secured £709,200 in fresh investment from an institutional backer keen to support its ongoing...
Hemogenyx Pharmaceuticals Aktie
5HU WKN A143YN ISIN GB00BYX3WZ24Aktuelle Nachrichten zu Hemogenyx Pharmaceuticals
Weitere Nachrichten
Das berichten andere über Hemogenyx Pharmaceuticals
Hemogenyx takes major step with AML treatment
Hemogenyx Pharmaceuticals PLC (LSE:HEMO, OTC:HOPHF) CEO Dr. Vladislav Sandler talked with Proactive about the company’s recent milestone—the first human...
Hemogenyx shares jump 13% as first-in-human trial of CAR-T therapy begins
Shares in Hemogenyx Pharmaceuticals PLC (LSE:HEMO, OTC:HOPHF) surged 13% in the first hour of trading after the company announced it had administered the...
Hemogenyx begins first-human-trial for potentially ground-breaking leukaemia treatment
Hemogenyx Pharmaceuticals PLC (LSE:HEMO, OTC:HOPHF) has taken a major step forward in its fight against acute myeloid leukaemia, announcing that it has...
Wir finden für unsere Leser softwaregestützt die besten Aktien der Welt
und schreiben darüber, wie man diese handeln muss, um Geld zu verdienen.